Fluoroquinolones and the risk of severe hypoglycemia among sulfonylurea users

被引：0
|
作者：
Dimakos, Jenny [1 ]
Cui, Ying [2 ]
Filion, Kristian B. [3 ]
Renoux, Christel [4 ]
Platt, Robert W. [4 ]
Douros, Antonios [5 ]
机构：
[1] McGill Univ, Dept Med, Montreal, PQ, Canada
[2] Lady Davis Inst, Montreal, PQ, Canada
[3] McGill Univ, Montreal, PQ, Canada
[4] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[5] Charite, Inst Clin Pharmacol & Toxicol, Berlin, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
194
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [31] Severe Hypoglycemia increases cardiovascular Risk
    Pavlicek, V.
    DIABETOLOGE, 2013, 9 (06): : 473 - 474
  • [32] Risk of Severe Upper Gastrointestinal Complications among Oral Bisphosphonate Users
    Ghirardi, Arianna
    Scotti, Lorenza
    Zambon, Antonella
    Della Vedova, Gianluca
    D'oro, Luca Cavalieri
    Lapi, Francesco
    Cipriani, Francesco
    Caputi, Achille P.
    Vaccheri, Alberto
    Gregori, Dario
    Gesuita, Rosaria
    Vestri, Annarita
    Staniscia, Tommaso
    Mazzaglia, Giampiero
    Corrao, Giovanni
    PLOS ONE, 2013, 8 (12):
  • [33] Severe Hypoglycemia: Who is at risk? Risk Factors identified
    不详
    DIABETOLOGE, 2018, 14 (04): : 211 - 211
  • [34] Metformin plus Insulin versus Metformin plus Sulfonylurea and the Associated Risk of Hypoglycemia
    Roumie, Christianne L.
    Min, JeaYoung
    Greevy, Robert A.
    Grijalva, Carlos
    Hung, Adriana M.
    Liu, Xulei
    Griffin, Marie R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 344 - 344
  • [35] Adherence to Metformin Monotherapy as a Risk Factor for Hypoglycemia after Intensifying Treatment with a Sulfonylurea
    Min, Jea Young
    Griffin, Marie R.
    Greevy, Robert A.
    Hackstadt, Amber
    Chipman, Jonathan
    Roumie, Christianne L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 260 - 260
  • [36] Risk factors for prolonged and non-prolonged hypoglycemia in sulfonylurea treated patients
    Holstein, A
    Plaschke, A
    Egberts, EH
    DIABETES, 2002, 51 : A491 - A492
  • [37] Trends and risk factors in severe hypoglycemia among individuals with type 2 diabetes in Korea
    Lee, Seung Eun
    Kim, Kyoung-Ah
    Son, Kang Ju
    Song, Sun Ok
    Park, Kyeong Hye
    Park, Se Hee
    Nam, Joo Young
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [38] INTRAMUSCULAR OR INTRAVENOUS GLUCAGON FOR SULFONYLUREA HYPOGLYCEMIA
    TAYLOR, JR
    SHERRATT, HSA
    DAVIES, DM
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (02) : 125 - 127
  • [39] Mitigating Severe Hypoglycemia in Users of Advanced Diabetes Technologies: Impaired Awareness of Hypoglycemia and Unhelpful Hypoglycemia Beliefs as Targets for Interventions
    Lin, Yu Kuei
    Ye, Wen
    Rogers, Helen
    Brooks, Augustin
    Toschi, Elena
    Kariyawasam, Dulmini
    Heller, Simon
    de Zoysa, Nicole
    Amiel, Stephanie A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 (10) : 739 - 747
  • [40] Mitigating Severe Hypoglycemia in Users of Advanced Diabetes Technologies: Impaired Awareness of Hypoglycemia and Unhelpful Hypoglycemia Beliefs as Targets for Interventions
    Lin, Yu Kuei
    Ye, Wen
    Rogers, Helen
    Brooks, Augustin
    Toschi, Elena
    Kariyawasam, Dulmini
    Heller, Simon
    de Zoysa, Nicole
    Amiel, Stephanie A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024,
12345